Eli Lilly and Company

NYSE (USD): Eli Lilly and Company (LLY)

Last Price

745.82

Today's Change

-4.10 (0.54%)

Day's Change

745.08 - 761.28

Trading Volume

2,192,467

Overview

Market Cap

708 Billion

Shares Outstanding

949 Million

Avg Volume

3,411,068

Avg Price (50 Days)

868.47

Avg Price (200 Days)

835.77

PE Ratio

80.46

EPS

9.27

Earnings Announcement

04-Feb-2025

Previous Close

749.92

Open

757.05

Day's Range

745.0812 - 761.2799

Year Range

561.65 - 972.53

Trading Volume

2,198,502

Price Change Highlight

1 Day Change

-0.54%

5 Day Change

-3.78%

1 Month Change

-17.96%

3 Month Change

-21.83%

6 Month Change

-7.11%

Ytd Change

25.95%

1 Year Change

25.34%

3 Year Change

186.38%

5 Year Change

541.87%

10 Year Change

1014.38%

Max Change

26442.95%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Drug Manufacturers—General

Description:

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment